Modern Healthcare Technology Holdings Management
Management criteria checks 3/4
Modern Healthcare Technology Holdings' CEO is Joyce Tsang, appointed in Apr 2010, has a tenure of 14.67 years. total yearly compensation is HK$15.79M, comprised of 99.5% salary and 0.5% bonuses, including company stock and options. directly owns 74.88% of the company’s shares, worth HK$63.66M. The average tenure of the management team and the board of directors is 12.8 years and 15 years respectively.
Key information
Joyce Tsang
Chief executive officer
HK$15.8m
Total compensation
| CEO salary percentage | 99.5% |
| CEO tenure | 14.7yrs |
| CEO ownership | 74.9% |
| Management average tenure | 12.8yrs |
| Board average tenure | 15yrs |
Recent management updates
Recent updates
A Look At The Fair Value Of Modern Healthcare Technology Holdings Limited (HKG:919)
Oct 04
Modern Healthcare Technology Holdings Limited (HKG:919) Not Doing Enough For Some Investors As Its Shares Slump 27%
Oct 04It Looks Like Modern Healthcare Technology Holdings Limited's (HKG:919) CEO May Expect Their Salary To Be Put Under The Microscope
Aug 21Investors Aren't Buying Modern Healthcare Technology Holdings Limited's (HKG:919) Revenues
Apr 08Investors Don't See Light At End Of Modern Healthcare Technology Holdings Limited's (HKG:919) Tunnel And Push Stock Down 29%
Dec 18Modern Healthcare Technology Holdings (HKG:919) Is Experiencing Growth In Returns On Capital
Jun 30Be Wary Of Modern Healthcare Technology Holdings (HKG:919) And Its Returns On Capital
May 04Modern Healthcare Technology Holdings (HKG:919) Is Reinvesting At Lower Rates Of Return
Jan 31Modern Healthcare Technology Holdings Limited's (HKG:919) Popularity With Investors Under Threat As Stock Sinks 29%
Dec 02Shareholders Will Probably Hold Off On Increasing Modern Healthcare Technology Holdings Limited's (HKG:919) CEO Compensation For The Time Being
Aug 20Should You Be Adding Modern Healthcare Technology Holdings (HKG:919) To Your Watchlist Today?
Apr 11Does Modern Healthcare Technology Holdings' (HKG:919) CEO Salary Compare Well With Industry Peers?
Feb 16
Are Modern Healthcare Technology Holdings's (HKG:919) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 13We're Watching These Trends At Modern Healthcare Technology Holdings (HKG:919)
Dec 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | HK$3m |
| Jun 30 2024 | n/a | n/a | -HK$3m |
| Mar 31 2024 | HK$16m | HK$16m | -HK$10m |
| Dec 31 2023 | n/a | n/a | -HK$50m |
| Sep 30 2023 | n/a | n/a | -HK$90m |
| Jun 30 2023 | n/a | n/a | -HK$55m |
| Mar 31 2023 | HK$13m | HK$13m | -HK$21m |
| Dec 31 2022 | n/a | n/a | -HK$3m |
| Sep 30 2022 | n/a | n/a | HK$14m |
| Jun 30 2022 | n/a | n/a | -HK$28m |
| Mar 31 2022 | HK$13m | HK$13m | -HK$69m |
| Dec 31 2021 | n/a | n/a | -HK$25m |
| Sep 30 2021 | n/a | n/a | HK$18m |
| Jun 30 2021 | n/a | n/a | HK$72m |
| Mar 31 2021 | HK$11m | HK$11m | HK$126m |
| Dec 31 2020 | n/a | n/a | HK$77m |
| Sep 30 2020 | n/a | n/a | HK$29m |
| Jun 30 2020 | n/a | n/a | -HK$1m |
| Mar 31 2020 | HK$10m | HK$10m | -HK$32m |
| Dec 31 2019 | n/a | n/a | -HK$15m |
| Sep 30 2019 | n/a | n/a | HK$3m |
| Jun 30 2019 | n/a | n/a | -HK$5m |
| Mar 31 2019 | HK$10m | HK$10m | -HK$13m |
| Dec 31 2018 | n/a | n/a | -HK$22m |
| Sep 30 2018 | n/a | n/a | -HK$32m |
| Jun 30 2018 | n/a | n/a | -HK$27m |
| Mar 31 2018 | HK$11m | HK$11m | -HK$23m |
Compensation vs Market: Joyce's total compensation ($USD2.03M) is above average for companies of similar size in the Hong Kong market ($USD230.70K).
Compensation vs Earnings: Joyce's compensation has been consistent with company performance over the past year.
CEO
Joyce Tsang (63 yo)
14.7yrs
Tenure
HK$15,785,000
Compensation
Dr. Yue Tsang, also known as Joyce, is Founder of Modern Beauty Salon Holdings Limited (Modern Healthcare Technology Holdings Limited) and has been its Chairperson and Chief Executive Officer since April 1...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 14.7yrs | HK$15.79m | 74.88% HK$ 63.7m | |
| CTO & Executive Director | no data | HK$772.00k | 0.020% HK$ 17.4k | |
| Financial Controller & Executive Director | no data | HK$876.00k | 0.019% HK$ 16.2k | |
| CFO & Company Secretary | 3.8yrs | no data | no data | |
| Chief Administrative Officer | 12.8yrs | HK$2.01m | 0.072% HK$ 61.1k | |
| Legal Counsel | no data | no data | no data |
12.8yrs
Average Tenure
54yo
Average Age
Experienced Management: 919's management team is seasoned and experienced (12.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 14.7yrs | HK$15.79m | 74.88% HK$ 63.7m | |
| CTO & Executive Director | 19.3yrs | HK$772.00k | 0.020% HK$ 17.4k | |
| Financial Controller & Executive Director | 12yrs | HK$876.00k | 0.019% HK$ 16.2k | |
| Independent Non-Executive Director | 15yrs | HK$264.00k | no data | |
| Independent Non-Executive Director | 15yrs | HK$264.00k | no data | |
| Independent Non-Executive Director | 15yrs | HK$324.00k | no data | |
| Independent Non-Executive Director | 1.2yrs | HK$132.00k | no data |
15.0yrs
Average Tenure
62yo
Average Age
Experienced Board: 919's board of directors are seasoned and experienced ( 15 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 07:32 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Modern Healthcare Technology Holdings Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Paul Quah | CLSA |